Antihypertensive drugs and risk of COVID-19?
- PMID: 32222167
- PMCID: PMC7194509
- DOI: 10.1016/S2213-2600(20)30156-9
Antihypertensive drugs and risk of COVID-19?
Comment in
-
Antihypertensive drugs and risk of COVID-19? - Authors' reply.Lancet Respir Med. 2020 May;8(5):e32-e33. doi: 10.1016/S2213-2600(20)30159-4. Epub 2020 Mar 26. Lancet Respir Med. 2020. PMID: 32222169 Free PMC article. No abstract available.
Comment on
-
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?Lancet Respir Med. 2020 Apr;8(4):e21. doi: 10.1016/S2213-2600(20)30116-8. Epub 2020 Mar 11. Lancet Respir Med. 2020. PMID: 32171062 Free PMC article. No abstract available.
-
Antihypertensive drugs and risk of COVID-19?Lancet Respir Med. 2020 May;8(5):e28. doi: 10.1016/S2213-2600(20)30158-2. Epub 2020 Mar 26. Lancet Respir Med. 2020. PMID: 32222168 Free PMC article. No abstract available.
References
-
- Ferrario CM, Jessup J, Chappell MC. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;111:2605–2610. - PubMed
-
- Hoffmann M, Kleine-Weber H, Krueger N, Mueller MA, Drosten C, Pöhlmann S. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. Jan 31, 2020. https://www.biorxiv.org/content/10.1101/2020.01.31.929042v1 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
